X0306 4 2022-09-01 0 0001438533 Travere Therapeutics, Inc. TVTX 0001943192 Cline Christopher R. C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DRIVE, STE 300 SAN DIEGO CA 92130 0 1 0 0 Chief Financial Officer Common Stock 2022-09-01 4 A 0 5000 0.00 A 33723 D Employee Stock option (right to buy) 28.06 2022-09-01 4 A 0 48000 0.00 A 2032-08-31 Common Stock 48000 48000 D Performance-based restricted stock units 2022-09-01 5 A 0 E 9840 0.00 A Common Stock 9840 9840 D The equity award vests over four years, with 1/4th vesting on each anniversary of the grant date. One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter. Each performance-based restricted stock unit represents a contingent right to receive one share of the Common Stock of the Issuer. This grant will vest upon the achievement of specified clinical/regulatory and commercial milestones, provided, however, if either vesting event occurs before the date that is 12 months after the date of grant, then the portion of the award that would have vested upon such event will instead vest on the date that is 12 months after the date of grant, and provided further that the Performance RSU will expire on January 31,2027 to the extent the specified performance based milestones are not achieved by such date. /s/ Elizabeth E. Reed, Attorney-in-Fact 2022-09-01